Trial intelligence / Profile preview

Melatonin, placebo, and light therapy for children with delayed sleep phase syndrome

NL-OMON28494Active, not recruiting

Sponsor
University of Amsterdam
Start
Oct 2013
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of melatonin in delayed sleep-wake phase disorder (DSPD) and circadian rhythm sleep disorder (CRSD) (3 arms), sponsored by University of Amsterdam. Primary endpoints: Dim light melatonin onset, Sleep onset time and 3 more. Started Oct 2013; status: active, not recruiting.

02

Drugs

melatonin
03

Conditions

delayed sleep-wake phase disorder (DSPD)circadian rhythm sleep disorder (CRSD)

Beyond the preview

Go deeper on NL-OMON28494.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON28494.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call